Close

NPS Pharma (NPSP) Target Raised to $45 at Janney

September 25, 2013 9:39 AM EDT Send to a Friend
Janney Montgomery Scott maintained a Buy rating on NPS Pharmaceuticals Inc. (NASDAQ: NPSP) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login